Table 2.
PREDICT [17] | TIMI [27] | PURSUIT [28] | FRISC II [29] | GRACE [18] | SYNERGY [30] | CRUSADE [19] | |
---|---|---|---|---|---|---|---|
Relevant population | MI or UA | UA or NSTEMI | UA or NSTEMI | UA or NSTEMI | Any ACS | NSTEMI or UA | NSTEMI aged ≥65 years |
Outcome | Death | Death, MI or urgent revascularization | Death or nonfatal MI | Death or death/MI | Death or death/MI | Death | Mortality |
Time horizon | 30 days, 2 years, 6 years | 14 days | 30 days | 1 year | 6 months | From 30 days to 1 year | 1 year |
Data source | Observational cohort study | RCT | RCT | RCT | Registry | RCT | Registry |
Items included | Age | Age | Age | Age | Age | Age | Age |
History of CVDb | Having ≥3 CHD risk factorsa | Gender | Gender | HR | Creatinine clearance | Serum creatinine | |
CHF at presentation Shock at presentation Kidney function ECG severity score (based on presence of Q wave, ST-segment deviation, bundle branch block) Charlson comorbidity index score |
Known CHD (≥50 % stenosis) Aspirin use in past 7 days Severe angina (≥2 episodes in 24 h) ECG changes of ≥0.5 mm Positive biomarker |
Worst CCS class in previous 6 weeks HR SBP Signs of heart failure ST depression on presenting ECG |
Diabetes Previous MI ST depression on admission Elevated biomarkers |
SBP Serum creatinine Killip class Cardiac arrest at admission ST-segment deviation Elevated cardiac enzymes/markers |
Weight Baseline hemoglobin level Baseline platelet count Nadir platelet count Atrial fibrillation/flutter Statin use in first 30 days since initial hospitalization CABG during first 30 days after initial hospitalization Gender |
SBP Signs of heart failure on presentation HR Weight Prior heart failure Hematocrit Troponin ratio Prior stroke Diabetes Gender Prior PAD |
TIMI risk score for UA/NSTEMI: http://www.mdcalc.com/timi-risk-score-for-uanstemi/
GRACE risk score for ACS: http://www.mdcalc.com/grace-acs-risk-and-mortality-calculator/
ACS acute coronary syndrome, CABG coronary artery bypass grafting, CCS Canadian Cardiovascular Society (angina measure), CHD coronary heart disease, CHF congestive heart failure, CVD cardiovascular disease, DM diabetes mellitus, ECG electrocardiogram, HR heart rate, MI myocardial infarction, NSTEMI non-ST-segment elevation myocardial infarction, PAD peripheral arterial disease, RCT randomized controlled trial, SBP systolic blood pressure, UA unstable angina
aFamily history of CHD, hypertension, hypercholesterolemia, diabetes, or current smoker
bHistory of MI, stroke, angina >8 weeks before admission, CABG, cardiac arrest and/or hypertension